Skip to contentC
Chemed Corp
C
CHEChemed Corp Q2 2026 · 10-Q
Revenue$673.25M$673.25M+8.8% vs Q2 2025 Net Income$67.70M$67.70M+29.0% vs Q2 2025 EPS Diluted$5.13$5.13+43.7% vs Q2 2025 Operating Income$89,204,000+31.0% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Chemed Corp · CIK 19584 · Engraved from SEC EDGAR
derived
Free Cash Flowderived$69,290,000−43.6% Margins · derivedOperating margin13.2%+2.2 pt vs Q2 2025
Net margin10.1%+1.6 pt vs Q2 2025
ended Jun 30, 2026 · filed Jul 31, 2026 · 31 d after period end